RMTI (Rockwell Medical) Enterprise Value: $13.64 Mil (As of Jun. 30, 2026) ***


RMTI Rockwell Medical Inc RMTI
30 GF Score
Price $0.59
GF Value $0.87
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Rockwell Medical Enterprise Value?

Rockwell Medical RMTI -10.33% 30 Enterprise Value is $13.64 Mil as of Jun. 30, 2026. GuruFocus rates RMTI with a GF Score™ of 30/100 and a GF Value™ of $0.87 (Possible Value Trap). The stock has 3 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Rockwell Medical's Enterprise Value is $13.64 Mil. Rockwell Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $-4.28 Mil. Therefore, Rockwell Medical's EV-to-EBIT ratio for today is -3.19.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Rockwell Medical's Enterprise Value is $13.64 Mil. Rockwell Medical's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-2.62 Mil. Therefore, Rockwell Medical's EV-to-EBITDA ratio for today is -5.20.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Rockwell Medical's Enterprise Value is $13.64 Mil. Rockwell Medical's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $67.68 Mil. Therefore, Rockwell Medical's EV-to-Revenue ratio for today is 0.20.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Rockwell Medical's Enterprise Value is $13.64 Mil. Rockwell Medical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $2.66 Mil. Therefore, Rockwell Medical's EV-to-OCF ratio for today is 5.13.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Rockwell Medical's Enterprise Value is $13.64 Mil. Rockwell Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $1.76 Mil. Therefore, Rockwell Medical's EV-to-FCF ratio for today is 7.76.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Rockwell Medical  (NAS:RMTI) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Rockwell Medical's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=13.641/-4.275
=-3.19

Rockwell Medical's current Enterprise Value is $13.64 Mil.
Rockwell Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.28 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Rockwell Medical's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=13.641/-2.622
=-5.20

Rockwell Medical's current Enterprise Value is $13.64 Mil.
Rockwell Medical's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.62 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Rockwell Medical's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=13.641/67.68
=0.20

Rockwell Medical's current Enterprise Value is $13.64 Mil.
Rockwell Medical's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $67.68 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Rockwell Medical's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=13.641/2.661
=5.13

Rockwell Medical's current Enterprise Value is $13.64 Mil.
Rockwell Medical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.66 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Rockwell Medical's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=13.641/1.757
=7.76

Rockwell Medical's current Enterprise Value is $13.64 Mil.
Rockwell Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rockwell Medical Enterprise Value Related Terms


Rockwell Medical Enterprise Value Historical Data

* Premium members only.

The historical data trend for Rockwell Medical's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rockwell Medical Enterprise Value Chart

Rockwell Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.99 7.22 57.56 61.41 20.32

Rockwell Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.25 24.78 36.70 20.32 25.75

RMTI vs CPHI, TXMD, MRMD: Enterprise Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rockwell Medical Enterprise Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Rockwell Medical's Enterprise Value falls into.


RMTI
30GF Score
Rockwell Medical Inc RMTI
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rockwell Medical Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Rockwell Medical's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

Rockwell Medical's Enterprise Value for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of $13.64 Mil mean?
Rockwell Medical (RMTI) has a Enterprise Value of $13.64 Mil as of Jun. 30, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Rockwell Medical and its competitors.
Is Rockwell Medical's Enterprise Value too high?
Rockwell Medical's current Enterprise Value is $13.64 Mil. Overall, Rockwell Medical has a GF Score™ of 30/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rockwell Medical's Enterprise Value compare to CPHI and TXMD?
Rockwell Medical's Enterprise Value of $13.64 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Rockwell Medical and its competitors. Rockwell Medical's current Enterprise Value is $13.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rockwell Medical stock overvalued right now?
Based on GuruFocus' analysis, Rockwell Medical (RMTI) is currently considered Possible Value Trap. The stock's GF Value™ is $0.87, compared to a current price of $0.59 — trading 32.6% below its estimated fair value. The current Enterprise Value is $13.64 Mil. Rockwell Medical's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Rockwell Medical (RMTI), the current Enterprise Value is $13.64 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rockwell Medical (RMTI) Overvalued in 2026?

Based on GuruFocus' analysis, Rockwell Medical stock appears to be undervalued. The current stock price of $0.59 is trading 32.6% below its estimated GF Value™ of $0.87. GuruFocus considers Rockwell Medical to be Possible Value Trap.

Key valuation signals for RMTI:

  • Enterprise Value: $13.64 Mil
  • GF Value™: $0.87 vs. price of $0.59 (32.6% below fair value)
  • GF Score™: 30/100 with 3 warning signs

No single metric tells the full story. See the RMTI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rockwell Medical Business Description

Other Exchanges RWMA:Germany
Address 30142 South Wixom Road, Wixom, MI, USA, 48393
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
30GF Score

Get the complete analysis for RMTI

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.59
Price
$0.87
GF Value